← Back
Data updated: Mar 29, 2026
PANACEA
CardiovascularNeurology
Generics
PANACEA is a generic drug manufacturer focused on Cardiovascular, Neurology.
2012
Since
3
Drugs
-
Trials
32
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Neurology 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2012-09-28
- Latest
- 2025-04-25
- Applications
- 3